Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side effects, including leukoencephalopathy. Although the prognosis is good-after cessation or dose reduction, complete recovery usually occurs-the differentiation with treatable diseases such as progressive multifocal encephalopathy can be difficult, making a stereotactic biopsy of the white matter lesion sometimes necessary. We describe the case of a 12-year-old girl with a severe, reversible tacrolimus-related leukoencephalopathy and only mild histopathologic abnormalities
Posterior reversible encephalopathy syndrome (PRES), is a group of disorders which may present with ...
(1) Background: Tacrolimus is an immunosuppressive agent commonly used in the management of solid or...
Leukoencephalopathy is a structural alteration of cerebral white matter mainly involving damage to m...
Item does not contain fulltextTacrolimus is an immunosuppressive agent that can show a wide variety ...
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side ef...
Tacrolimus is an immunosuppressive agent that can show a wide variety of neurological side effects, ...
WOS: 000283567300011PubMed ID: 20933182Posterior reversible encephalopathy syndrome, a serious neuro...
Previously described neurologic damage induced by immunosuppressive treatments includes transient or...
internuclear ophthalmoplegia developed in a 30-year-old woman 84 days after she received a matched, ...
INTRODUCTION: Tacrolimus is routinely used to prevent rejection after organs’ transplantation. Neuro...
Posterior reversible encephalopathy syndrome (PRES) is a neuroradiologic syndrome. The etiology of P...
<div><p>ABSTRACT Introduction: Posterior reversible leukoencephalopathy syndrome (PRES) was first d...
Liver transplantation is suitable for acute and chronic liver diseases that cannot be cured by other...
Tacrolimus is an immunosuppressive drug used to lower the risk of transplant rejection in individual...
Posterior reversible encephalopathy syndrome (PRES) is known to occur after solid organ transplantat...
Posterior reversible encephalopathy syndrome (PRES), is a group of disorders which may present with ...
(1) Background: Tacrolimus is an immunosuppressive agent commonly used in the management of solid or...
Leukoencephalopathy is a structural alteration of cerebral white matter mainly involving damage to m...
Item does not contain fulltextTacrolimus is an immunosuppressive agent that can show a wide variety ...
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side ef...
Tacrolimus is an immunosuppressive agent that can show a wide variety of neurological side effects, ...
WOS: 000283567300011PubMed ID: 20933182Posterior reversible encephalopathy syndrome, a serious neuro...
Previously described neurologic damage induced by immunosuppressive treatments includes transient or...
internuclear ophthalmoplegia developed in a 30-year-old woman 84 days after she received a matched, ...
INTRODUCTION: Tacrolimus is routinely used to prevent rejection after organs’ transplantation. Neuro...
Posterior reversible encephalopathy syndrome (PRES) is a neuroradiologic syndrome. The etiology of P...
<div><p>ABSTRACT Introduction: Posterior reversible leukoencephalopathy syndrome (PRES) was first d...
Liver transplantation is suitable for acute and chronic liver diseases that cannot be cured by other...
Tacrolimus is an immunosuppressive drug used to lower the risk of transplant rejection in individual...
Posterior reversible encephalopathy syndrome (PRES) is known to occur after solid organ transplantat...
Posterior reversible encephalopathy syndrome (PRES), is a group of disorders which may present with ...
(1) Background: Tacrolimus is an immunosuppressive agent commonly used in the management of solid or...
Leukoencephalopathy is a structural alteration of cerebral white matter mainly involving damage to m...